Fenofibrate decreases plasma ceramide in type 2 diabetes patients: A novel marker of CVD?
Croyal M, Kaabia Z, León L, Ramin-Mangata S, Baty T, Fall F, Billon-Crossouard S, Aguesse A, Hollstein T, Sullivan DR, Nobecourt E, Lambert G, Krempf M.
Croyal M, et al. Among authors: sullivan dr.
Diabetes Metab. 2018 Mar;44(2):143-149. doi: 10.1016/j.diabet.2017.04.003. Epub 2017 May 9.
Diabetes Metab. 2018.
PMID: 28499696
Clinical Trial.